Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Alteplase and Cerebrolysin in Acute Ischemic Hemispheric Stroke
2004-001729-11Phase 3Completed
- Sponsor
- EBEWE Pharma
- Start
- Jan 2005
- Modality
- Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Native Peptides → Peptides, Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Alteplase + Cerebrolysin with Alteplase + placebo (2 arms). Primary endpoint: Modified Rankin Scale at day 90. Started Jan 2005; status: completed.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2004-001729-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001729-11.